ENTPD1 and COVID-19: This study aims to evaluate the dynamics of Treg cell subsets and the expression patterns of ectonucleotidases (CD39 and CD73) during acute COVID-19 and the convalescent period, to better understand the pathogenesis of the disease and its long-term immune-mediated complications.